Sana biotechnology to present at september 2022 investor conferences

Seattle, sept. 09, 2022 (globe newswire) -- sana biotechnology, inc. (nasdaq: sana), a company focused on creating and delivering engineered cells as medicines, today announced that it will webcast its presentations at two investor conferences in september. the presentations will feature a business overview and update by steve harr, sana's president and chief executive officer.

SANA Ratings Summary

SANA Quant Ranking